Becton, Dickinson and Company (BD) has treated the first subject in the randomised multi-centre STANCE trial with GalaFLEX ...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the appointment ...

has announced that its board of directors has unanimously authorized a plan to separate BD's Biosciences and Diagnostic ...

In keeping with the trend in med tech to return to basics, Becton, Dickinson and Co. plans to split off its biosciences and diagnostic solutions unit to create two pure-play companies. The ‘New BD’ or ...

Becton Dickinson BDX1.08%increase; green up pointing triangle and Co. said it plans to break off its bioscience and diagnostic solutions business to focus on medical technology. Chief Executive ...

As the company pursues this transaction, BD will remain focused on execution and continue to operate the Biosciences and Diagnostic Solutions business and the other BD businesses in alignment with ...

BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care.

At BD Life Sciences–Biosciences (BDB), we take pride in our ... throughout their journey from basic to translational and clinical research to clinical diagnostics. Never miss a story ...

The family of BD Horizon RealYellow™ and BD Horizon RealBlue™ Reagents is bright, clean and laser specific to help streamline the path to your scientific discoveries. Driven by next-generation BD® dye ...